Biotech Stocks: 5 Best Performing So Far This Year #janssen #pharma

Posted On Jul 13 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) #astellas #pharma

Posted On Jul 10 2017 by

#small pharma companies # The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) The biotechnology sector is responsible for many discoveries and innovations that have come to health care. Biotechnology companies have a sole purpose of finding treatments for many of the diseases that plague society. These companies spend billions of dollars in research and development. most of the time finding little success. However, when a treatment is found and patients respond in a positive manner, it could result in blockbuster profits. Unlike large-cap biotechnology companies such as Amgen or Gilead, small-cap companies operate on a …


India – s first CRM for Pharma used by 10k Medical Reps in 5 countries

Posted On Jul 9 2017 by

#crm for pharma # Mobile Daily Call Reporting(DCR) Medismo On Demand Healthcare Mobile CRM lets you report from anywhere. MRs can Track Doctor Previous Call History, Stop False Reporting via GPS Tracking. Use the power of Medismo Pharma Mobile CRM to track your Medical rep locations and travel expenses sitting in Head Office. Pharma CRM in SaaS The BI Reporting engine can give reports in Realtime to track sales sales funnel so that the Managers can take proactive action. CEOs and Managers have access to a Single screen snapshot of sales, performance, competitor activity, expenses to the company much more. …


UCB to buy Schwarz Pharma for $5 #pharmaceutical #formulation #companies

Posted On Jul 8 2017 by

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …


FierceCRO – s Top 5 Strategic CRO #jobs #in #pharmacy

Posted On Jul 5 2017 by

#cro pharma # FierceCRO s Top 5 Strategic CRO/Pharma Partnerships Contract research organizations go back decades, but it is only within the past few years that they have coalesced as their own force in the biotech industry. A noticeable shift occurred in outsourcing research and clinical work when Big Pharma R D costs skyrocketed. Companies like Sanofi ($SNY), Eli Lilly ($LLY) and Pfizer ($PFE) began turning to CROs to help with the budget pressures. That in turn led to the global rise of drug development outsourcing and that is what led us to launch FierceCRO in February. As the demand …


The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) #asia #pharma

Posted On Jul 5 2017 by

#small pharma companies # The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) The biotechnology sector is responsible for many discoveries and innovations that have come to health care. Biotechnology companies have a sole purpose of finding treatments for many of the diseases that plague society. These companies spend billions of dollars in research and development. most of the time finding little success. However, when a treatment is found and patients respond in a positive manner, it could result in blockbuster profits. Unlike large-cap biotechnology companies such as Amgen or Gilead, small-cap companies operate on a …


India – s first CRM for Pharma used by 10k Medical Reps in 5 countries

Posted On Jul 5 2017 by

#crm for pharma # Mobile Daily Call Reporting(DCR) Medismo On Demand Healthcare Mobile CRM lets you report from anywhere. MRs can Track Doctor Previous Call History, Stop False Reporting via GPS Tracking. Use the power of Medismo Pharma Mobile CRM to track your Medical rep locations and travel expenses sitting in Head Office. Pharma CRM in SaaS The BI Reporting engine can give reports in Realtime to track sales sales funnel so that the Managers can take proactive action. CEOs and Managers have access to a Single screen snapshot of sales, performance, competitor activity, expenses to the company much more. …


UCB to buy Schwarz Pharma for $5 #bdi #pharma

Posted On Jul 3 2017 by

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …


The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) #jazz #pharma

Posted On Jun 14 2017 by

#small pharma companies # The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) The biotechnology sector is responsible for many discoveries and innovations that have come to health care. Biotechnology companies have a sole purpose of finding treatments for many of the diseases that plague society. These companies spend billions of dollars in research and development. most of the time finding little success. However, when a treatment is found and patients respond in a positive manner, it could result in blockbuster profits. Unlike large-cap biotechnology companies such as Amgen or Gilead, small-cap companies operate on a …


Biotech Stocks: 5 Best Performing So Far This Year #pharmaceutical #manufacturers #association

Posted On May 20 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …